With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting Neovascularization in Graft-Versus-Host Disease||Memorial Sloan-Kettering Cancer Center / Marcel van den Brink, MD/PhD||Innovation Grants||2012||New York|
|Targeting Novel Pediatric-Specific FLT3 Mutations||Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD,PhD||Reach Grants||2015||Washington|
|Targeting Oncogenic RAS in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD/PhD||Innovation Grants||2018||Massachusetts|
|Targeting Pediatric Brain Tumors Using PTPmu Nanochains with Radiofrequency-Releasable Therapeutics||Case Western Reserve University / Susann Brady-Kalnay, PhD & Efstathios Karathanasis, PhD||Innovation Grants||2017||Ohio|
|Targeting Pediatric Brainstem Glioma with Oncolytic Polioviruses.||Duke University Medical Center / Matthias Gromeier, MD||Innovation Grants||2006||North Carolina|
|Targeting PI3Kdelta in Childhood Acute Lymphoblastic Leukemia||Children's Hospital Los Angeles / Yong-mi Kim, MD & Nora Heisterkamp, PhD||Reach Grants||2015||California|
|Targeting PLK1 as a Common Mechanism in Ph-like ALL||University of Texas M.D. Anderson Cancer Center / Joya Chandra, PhD||Reach Grants||2016||Texas|
|Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia||Vanderbilt University Medical Center / Emmanuel Volanakis||Young Investigator Grants||2011||Tennessee|
|Targeting Protein Translation to Antagonize MYC-driven Neuroblastoma||Children's Hospital of Philadelphia / Andrea Flynn, MD||Young Investigator Grants||2017||Pennsylvania|
|Targeting RNA Helicase DDX3 to Treat Recurrent High Grade Sarcoma||The Johns Hopkins University School of Medicine / David Loeb, MD, PhD||Reach Grants||2013||Maryland|